The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
// STATE LEGISLATION TRACKER

Ohio HB 803: License advanced practice respiratory therapists

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed
State
Ohio
Bill
HB 803
Filed
2020-12-08
Read the bill
OpenStates →
Last reviewed
2026-10-02

Plain-English Summary

Ohio HB803 would create a license for advanced practice respiratory therapists and let them practice under physician supervision, including limited physician-delegated prescribing. It does not appear to target compounded peptides, 503A/503B pharmacies, naturopaths, NPs, telehealth prescribing, or off-label peptide access.

Key Points

  • No peptide-specific access changes are apparent.
  • No 503A or 503B compounding changes are apparent.
  • NP and naturopath peptide prescribing are not the focus.
  • Prescribing authority is for advanced respiratory therapists under physician supervision.
  • Controlled-substance and drug-database rules appear tied to that new respiratory role.

What to Watch For

i
Note This is mainly a respiratory-care scope bill, not a peptide or compounding bill.
i
Note Any prescribing expansion appears limited by physician supervision and respiratory practice scope.
i
Note Drug monitoring provisions matter for opioids and benzodiazepines, not typical peptide use.

Where the Bill Stands

The bill was introduced in Ohio's 133rd General Assembly, which ended without this bill becoming law.
· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws